About the Event
In this installment of Neurology Grand Rounds, Gil I. Wolfe, M.D., FAAN, presents “Myasthenia Gravis: The Evolving Therapeutic Landscape.” Wolfe is the chief of service for neurology and a SUNY Distinguished Professor in the Department of Neurology at the Jacobs School of Medicine and Biomedical Sciences at the University of Buffalo.
For in-person attendees, please arrive by 7:15 a.m. Breakfast will be served.
Email Bridgette Lakoski for the Zoom information.
Objectives
By the end of this presentation, the audience participant should be able to:
- Recognize the mechanisms of action being explored in new therapeutics for myasthenia gravis.
- Identify new agents available and those in the late stages of investigation for myasthenia gravis and how they might be used.
- Review and integrate the recent update to the International Consensus Guidance to manage myasthenia gravis.
Target Audience
- Primary: Neurosurgeons, neurologist and other medical specialties
- Secondary: Nursing staff, residents, students and allied health professions
Attributes/Competencies
This activity has been designed to promote some of the following desired physician attributes and competencies:
- ACGME: Patient Care and Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement, Interpersonal and Communication Skills, Professionalism, Systems-based Practice
- IOM: Provide patient-centered care, Work in interdisciplinary teams, Employ evidence-based practice, Apply quality improvement, Utilize informatics
- IECC: Values/Ethics for Interprofessional Practice, Roles/Responsibility, Interprofessional Communication, Teams and Teamwork
Speaker Disclosure
Gil I. Wolfe, M.D., FAAN, speaker for this educational activity, is a consultant/member of the speakers bureau for Alexion; a consultant/member of the DSMB for Cartesian; a consultant for Argenx and Johnson & Johnson; and a consultant for Immunovant and UCB/Ra, where he also received research support. All relevant financial relationships listed for this individual has been mitigated.
Planner Disclosure
Ethan Meltzer, M.D.; E. Steve Roach, M.D.; Kent Ellington, M.D.; Catherine Kronfol, M.D.; Marina Moore, D.O.; Bridgette Lakoski; Jacqueline Jackson; and Sarah Sanders, planners for this educational activity, have no relevant relationships with ineligible companies to disclosure.
The CME Advisory Committee, reviewers of this educational activity, have no relevant relationships with ineligible companies to disclose.
Accreditation Statement
The University of Texas at Austin Dell Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Texas at Austin Dell Medical School designates this internet live course for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This course has been designated by The University of Texas at Austin Dell Medical School for 1 credit(s) of education in medical ethics and/or professional responsibility.